The best indicator for Huntington Ingalls Industries (HII)
We backtested 20 indicators across daily, weekly and hourly charts on real Huntington Ingalls Industries (HII) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Huntington Ingalls Industries (HII) over ~15.2 years — beating buy-and-hold by 1.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Daily | 17.4% | 0.91 | -27.8% | 50.0% | 30 | 1.2% |
| 2 | MACD ✓ | Weekly | 14.7% | 0.81 | -35.0% | 51.7% | 29 | -1.1% |
| 3 | RSI Trend (>50) ✓ | Daily | 14.6% | 0.8 | -30.7% | 42.9% | 177 | -1.7% |
| 4 | Donchian Breakout ✓ | Daily | 12.7% | 0.77 | -30.6% | 48.1% | 52 | -3.6% |
| 5 | Bollinger Breakout ✓ | Daily | 10.4% | 0.75 | -22.0% | 60.9% | 69 | -5.8% |
| 6 | Rate of Change ✓ | Weekly | 13.6% | 0.73 | -40.5% | 53.8% | 39 | -2.3% |
| 7 | EMA-10 Trend ✓ | Weekly | 12.6% | 0.73 | -42.7% | 50.9% | 55 | -3.2% |
| 8 | Donchian Midline ✓ | Weekly | 12.8% | 0.7 | -38.0% | 44.4% | 36 | -3.0% |
| 9 | RSI Trend (>50) ✓ | Weekly | 12.3% | 0.67 | -39.0% | 50.0% | 32 | -3.6% |
| 10 | Heikin-Ashi Trend ✓ | Weekly | 11.6% | 0.67 | -32.8% | 54.8% | 135 | -4.2% |
| 11 | Donchian Midline ✓ | Daily | 11.2% | 0.65 | -35.1% | 44.9% | 205 | -5.0% |
| 12 | Donchian Breakout ✓ | Weekly | 12.5% | 0.71 | -37.9% | 76.9% | 13 | -3.3% |
| 13 | ADX / DMI ✓ | Daily | 8.9% | 0.6 | -30.0% | 51.4% | 105 | -7.4% |
| 14 | EMA-10 Trend ✓ | Daily | 8.7% | 0.53 | -27.7% | 44.6% | 334 | -7.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Huntington Ingalls Industries (HII), EMA 20/50 Cross on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.